Progressive multiple sclerosis
D Ontaneda, RJ Fox - Current opinion in neurology, 2015 - journals.lww.com
PMS represents a significant challenge, as the pathogenesis of the disease is not well
understood, no validated outcome metrics have been established and clinical trial …
understood, no validated outcome metrics have been established and clinical trial …
Progressive multiple sclerosis
D Ontaneda, RJ Fox - Current opinion in neurology, 2015 - pubmed.ncbi.nlm.nih.gov
Purpose of review The purpose of this study is to highlight the pathological features and
clinical aspects of progressive multiple sclerosis (PMS) and also the results of clinical trial …
clinical aspects of progressive multiple sclerosis (PMS) and also the results of clinical trial …
[HTML][HTML] Progressive multiple sclerosis
D Ontaneda, RJ Fox - Current opinion in neurology, 2015 - ncbi.nlm.nih.gov
PMS represents a significant challenge, as the pathogenesis of the disease is not well
understood, no validated outcome metrics have been established, and clinical trial …
understood, no validated outcome metrics have been established, and clinical trial …
Progressive multiple sclerosis.
D Ontaneda, RJ Fox - Current Opinion in Neurology, 2015 - europepmc.org
PMS represents a significant challenge, as the pathogenesis of the disease is not well
understood, no validated outcome metrics have been established and clinical trial …
understood, no validated outcome metrics have been established and clinical trial …
[引用][C] Progressive multiple sclerosis
D Ontaneda, RJ Fox - Current Opinion in Neurology, 2015 - cir.nii.ac.jp
Progressive multiple sclerosis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士論文を …
Progressive multiple sclerosis.
D Ontaneda, RJ Fox - Current Opinion in Neurology, 2015 - europepmc.org
PMS represents a significant challenge, as the pathogenesis of the disease is not well
understood, no validated outcome metrics have been established and clinical trial …
understood, no validated outcome metrics have been established and clinical trial …